Definium Therapeutics (DFTX) Intangibles (2021 - 2023)

Definium Therapeutics (DFTX) has reported Intangibles for 3 consecutive years, with $527000.0 the latest figure, recorded in Q4 2023.

• In Q4 2023, Intangibles fell 85.71% year-over-year to $527000.0; the TTM figure through Dec 2023 stood at $527000.0 (down 85.71% YoY), while the FY2023 annual figure was $527000.0, down 85.71% from the prior year.
• Intangibles slipped to $527000.0 in Q4 2023 per DFTX's latest filing, from $1.3 million in the prior quarter.
• Across five years, Intangibles topped out at $6.9 million in Q4 2021 and bottomed at $527000.0 in Q4 2023.
• Historically, Intangibles has averaged $3.7 million across 3 years, with a median of $3.7 million in 2022.
• Annual changes were most pronounced in 2022 — Intangibles plunged 46.29% — and 2023, when it plunged 85.71%.
• Definium Therapeutics' Intangibles stood at $6.9 million in 2021, then slumped by 46.29% to $3.7 million in 2022, then sank by 85.71% to $527000.0 in 2023.
• Business Quant data shows DFTX's Intangibles at $527000.0 in Q4 2023, $1.3 million in Q3 2023, and $2.1 million in Q2 2023.